GATA2 and epidermolysis bullosa: A recent preclinical study demonstrates increased BCL-2 expression and specific alterations in apoptosis-related proteins in patients with GATA2-related MDS-EB compared to GATA2 patients with RCC or patients with RCC and MDS-EB without GATA2 deficiency.